Search Results - "breast cancer"

Antibody-mediated drug delivery systems concepts, technology, and applications /

Table of Contents: “…Torchilin -- Antibody mediated drug delivery systems for breast cancer therapeutics / Leonor Munoz Alcivar and Y.V. …”
An electronic book accessible through the World Wide Web; click to view

Antibody-mediated drug delivery systems concepts, technology, and applications /

Table of Contents: “…Torchilin -- Antibody mediated drug delivery systems for breast cancer therapeutics / Leonor Munoz Alcivar and Y.V. …”
An electronic book accessible through the World Wide Web; click to view

The South Texas Health Status Review A Health Disparities Roadmap /

Get full text

The South Texas Health Status Review A Health Disparities Roadmap /

Get full text

Antibody-drug conjugates : fundamentals, drug development, and clinical outcomes to target cancer /

Table of Contents: “…Schmidt, Manish Gupta -- Antibody-drug conjugates (ADCs) in clinical development / Patricia LoRusso and Joseph McLaughlin -- ADCs approved for use : Trastuzumab emtansine (Kadcyla, T-DM1) in patients with previously treated HER2-positive metastatic breast cancer / Gail Lewis Phillips, Sanne de Hass, Sandhya Girish, and Ellie Guardino -- ADCs approved for use : Brentuximab Vedotin / Sven DeVos and Monica Mead -- Radioimmunotherapy / Jeffrey Wong and Savita Dandapani -- Radiolabeled antibody-based imaging in clinical oncology / Bart Hendriks and Daniel Gaddy -- Antibody-drug conjugates : the next evolution in the cure for cancer -- William C. …”
An electronic book accessible through the World Wide Web; click to view

Antibody-drug conjugates : fundamentals, drug development, and clinical outcomes to target cancer /

Table of Contents: “…Schmidt, Manish Gupta -- Antibody-drug conjugates (ADCs) in clinical development / Patricia LoRusso and Joseph McLaughlin -- ADCs approved for use : Trastuzumab emtansine (Kadcyla, T-DM1) in patients with previously treated HER2-positive metastatic breast cancer / Gail Lewis Phillips, Sanne de Hass, Sandhya Girish, and Ellie Guardino -- ADCs approved for use : Brentuximab Vedotin / Sven DeVos and Monica Mead -- Radioimmunotherapy / Jeffrey Wong and Savita Dandapani -- Radiolabeled antibody-based imaging in clinical oncology / Bart Hendriks and Daniel Gaddy -- Antibody-drug conjugates : the next evolution in the cure for cancer -- William C. …”
An electronic book accessible through the World Wide Web; click to view

Drug resistant neoplasms

Table of Contents: “…Michael -- Inherent and microenvironment-mediated mechanisms of drug resistance / Malathy P.V Shekhar -- Studies on the mechanisms of acquired resistance to EGFR tyrosine kinase inhibitor gefitinib in NSCLC cell lines: evidence that ligand-induced endocytosis of EGFR via the early/late endocytic pathway is associated with gefitinib sensitivity of NSCLC cell line / Yukio Nishimura -- Mechanisms of resistance to EGF receptor-tyrosine kinase inhibitor in NSCLC cell lines: gefitinib sensitivity is closely correlated with ligand-induced endocytosis of phosphorylated EGF receptor / Yukio Nishimura, Kiyoko Yoshioka and Kazuyuki Itoh -- Targeting adverse features of hormone-resistant breast cancer / Stephen Hiscox ... [et al.] -- Systematic analysis of patterns of cross resistance between anticancer agents / Britta Stordal and Ross Davey -- Molecular structure and energy: clinical importance in drug resistant neoplasms / Viroj Wiwanitkit -- Treating drug resistant malignancy / Viroj Wiwanitkit -- Overcoming ovarian cancer drug resistance with phytochemicals and other compounds / Marion M. …”
An electronic book accessible through the World Wide Web; click to view

Drug resistant neoplasms

Table of Contents: “…Michael -- Inherent and microenvironment-mediated mechanisms of drug resistance / Malathy P.V Shekhar -- Studies on the mechanisms of acquired resistance to EGFR tyrosine kinase inhibitor gefitinib in NSCLC cell lines: evidence that ligand-induced endocytosis of EGFR via the early/late endocytic pathway is associated with gefitinib sensitivity of NSCLC cell line / Yukio Nishimura -- Mechanisms of resistance to EGF receptor-tyrosine kinase inhibitor in NSCLC cell lines: gefitinib sensitivity is closely correlated with ligand-induced endocytosis of phosphorylated EGF receptor / Yukio Nishimura, Kiyoko Yoshioka and Kazuyuki Itoh -- Targeting adverse features of hormone-resistant breast cancer / Stephen Hiscox ... [et al.] -- Systematic analysis of patterns of cross resistance between anticancer agents / Britta Stordal and Ross Davey -- Molecular structure and energy: clinical importance in drug resistant neoplasms / Viroj Wiwanitkit -- Treating drug resistant malignancy / Viroj Wiwanitkit -- Overcoming ovarian cancer drug resistance with phytochemicals and other compounds / Marion M. …”
An electronic book accessible through the World Wide Web; click to view

Field guide to internal medicine / by Smith, David S. (David Scott), 1954-

Table of Contents: “…Mesmer -- Myeloproliferative disorders / Richard Mark White -- Multiple myeloma / Richard Mark White -- Breast cancer / Meredith Talbot -- Lung cancer / H. Klar Yaggi -- Colorectal cancer / Richard Mark White -- Esophageal cancer / Michael A. …”
An electronic book accessible through the World Wide Web; click to view

Field guide to internal medicine / by Smith, David S. (David Scott), 1954-

Table of Contents: “…Mesmer -- Myeloproliferative disorders / Richard Mark White -- Multiple myeloma / Richard Mark White -- Breast cancer / Meredith Talbot -- Lung cancer / H. Klar Yaggi -- Colorectal cancer / Richard Mark White -- Esophageal cancer / Michael A. …”
An electronic book accessible through the World Wide Web; click to view